miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

about

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

Item

http://www.wikidata.org/entity/Q52670018

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

@en

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

@nl

type

Item

label

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

@en

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

@nl

prefLabel

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

@en

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

@nl

P1476

miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.

@en

P2093

Feng Guo

http://www.w3.org/2001/XMLSchema#string

Xiu-Hua Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Real-time quantification of microRNAs by stem-loop RT-PCR

The promise of immunotherapy in head and neck squamous cell carcinoma

Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.

Characterization of the Melanoma miRNAome by Deep Sequencing

Improved survival with bevacizumab in advanced cervical cancer

Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4

The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.

Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer.

Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).

P304

6397-6404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2018.8697

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29512734

http://www.w3.org/2001/XMLSchema#string

P932

5928616

http://www.w3.org/2001/XMLSchema#string